Communiqués Getinge AB Deutsche Boerse AG

Actions

GTN

SE0000202624

Equipement, fournitures et distribution médicale

Temps réel estimé Tradegate Autres places de cotation 10:51:43 06/07/2026			Varia. 5j.	Varia. 1 janv.
18,80 ^EUR	+1,75%		+5,36%	-6,04%

03/07	Fin de semaine enthousiaste a la Bourse de Stockholm, l'indice OMXS30 grimpe de 1,1 pour cent	FW
03/07	Getinge obtient un remboursement de droits de douane de 36 millions de dollars	MT

Communiqués

03/07	Getinge receives refund of tariffs paid under IEEPA	AQ
03/07	Getinge invites fund managers, analysts, and media to Q2 Report 2026 conference call	AQ
02/06	Getinge Launches Vasoview Hemopro 3, Advancing Endoscopic Vessel Harvesting	AQ
28/05	Getinge's subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.	AQ
21/04	Resolutions at Getinge's Annual General Meeting April 21, 2026	AQ
21/04	Getinge : Presentation Q1 2026	PU
21/04	Getinge : Q1 Report 2026	PU
21/04	Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone	AQ
16/04	Getinge – Consensus estimates Q1 2026	AQ
07/04	Getinge : invites fund managers, analysts, and media to Q1 Report 2026 conference call	PU
26/03	Getinge : Auditors Report 2025	PU
26/03	Getinge publishes Annual Report for 2025	AQ
12/03	Getinge : Pre-close brief Q1 2026	PU
12/03	NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL)	AQ
27/01	Getinge : Presentation Helårsrapport 2025	PU
27/01	Getinge : Justerade siffror 2025	PU
27/01	Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year	AQ
22/01	Getinge – Consensus estimates Q4 2025	AQ
13/01	Getinge invites fund managers, analysts, and media to Year-End Report 2025 conference call	AQ
18/12	Camilla Sylvest is proposed for Getinge AB's Board of Directors	AQ
26/11	SteriPro International and Getinge Announce Strategic Partnership to Expand Off-Site Sterile Processing Capacity Across North America	AQ
21/10/25	Getinge : Presentation Q3 2025	PU
21/10/25	Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds	AQ
16/10/25	Getinge – Consensus estimates Q3 2025	AQ
13/10/25	Getinge's Advanta V12 receives CE Mark for major bridging indications	AQ